Newly-released Biopsy Guidance System Market analysis report by Future Market Insights shows that global sales of the Biopsy Guidance System Market in 2021 were held at US$ 1.1 Billion. With a CAGR of 5.8% from 2022 to 2032, the market is projected to reach a valuation of US$ 2 Billion by 2032. The market for Stereotactic Guided Biopsy is expected to be the highest revenue-generating segment expected to grow at a CAGR of 6.1% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Biopsy Guidance System Market (2022) | US$ 458 Million |
| Global Biopsy Guidance System Market (2032) | US$ 2 Billion |
| Global Biopsy Guidance System Market CAGR (2022 to 2032) | 5.8% |
| USA Biopsy Guidance System Market (2022) | US$ 444 Million |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Biopsy Guidance System Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Biopsy Guidance System Market increased at around 5.1% CAGR.
The rising prevalence of cancer, the rise in the geriatric population, the rising demand for non-invasive procedures, technological innovations, and government initiatives, are the key drivers for the market. A biopsy is one of the most common procedures for diagnosing cancer and other chronic diseases, and it is used to diagnose breast, brain, skin, and prostate cancers.
The rising incidence of cancer is one of the major drivers of market expansion. Because the biopsy guidance system is one of the most important requirements for the initial diagnosis of cancer, the market is expected to grow at a rapid pace over the forecast period.
As a result of the substantial increase in the incidence of cancer, more advanced technology, safer, and more effective biopsies are being developed, which is driving the biopsy market. Non-invasive procedures are becoming more popular, which is fueling market growth in that area.
Patients owing to the high costs and painful side effects that come with this treatment, resulting in undiagnosed or inadequate diseases later in life, often avoid invasive biopsies. These symptoms consequently increase mortality rates and lead to greater expenses and difficulties in treatment.
The demand for non-invasive procedures is skyrocketing owing to the boost in demand for biopsy guidance systems, resulting in a surge in the need for biopsy guidance systems. Patients recover faster and are less traumatized as a result of these procedures. Owing to these factors, Biopsy Guidance System Market is projected to grow at a CAGR of 5.8 % over the coming 10 years.
When the tumor is located deep within the body, image-guided biopsies are used. Biopsy guidance systems are both cost-effective and simple to operate. They can provide superb real-time details that cause the procedure to be less uncomfortable and more efficient for the patient. Furthermore, these guided biopsies can enable to rapid inspect numerous lesions in the axillary and sub-areolar areas.
The segment is growing due to the rising demand for robotic biopsies due to their less invasive nature. A rising number of product launches, combined with quick FDA approval, are also contributing to the segment's growth.
Increased awareness of biopsy guidance systems, increased healthcare infrastructure development, impressive reimbursement policies, increased investment in healthcare research and development, and an upsurge in the number of hospitals and diagnostic centers are expected to drive demand for biopsy guidance systems during the forecast period.
Principal Consultant
North America accounts for the largest market share during the forecast period. Because of factors such as improved infrastructure, rising patient awareness, and the presence of key players in the region also the presence of a large number of academic institutes, enhanced healthcare infrastructure, and Research and Development institutes are all contributing to the market's growth. In addition, the USA has a large number of market participants.
On the other hand, the market in the Asia Pacific is expected to grow at the fastest pace with an absolute dollar opportunity of US$ 880 Million during the forecast period. The presence of leading manufacturers in countries such as Japan, as well as a growing number of local producers in countries like China and India, are driving the regional market forward.
Over the projected period, the market is expected to be fuelled by an increasing number of healthcare institutions, the rising need for diagnostic centers, and expanding Research and Development projects. The market is expected to grow over the forecast period, owing to an increase in the number of cancer cases and advancements in biopsy guidance systems.
USA Biopsy Guidance System Market Analysis
The USA is expected to account for the largest market of US$ 771.4 Million by the end of 2032. This is attributable to a significant increase in research & development activities. Furthermore, advances in the healthcare industry have resulted in the development of new technologies and equipment, which is further expected to boost the market in the USA. Furthermore, the presence of well-known corporations, as well as early access to new and developing technologies, is projected to aid the market in the USA in maintaining its global market supremacy in the next years.
China Biopsy Guidance Market Analysis
The market in China is expected to grow at a CAGR of 7.1% during the forecast period, approaching a market revenue of US$ 230.9 Million by 2032. In Asian countries, traditional biopsy techniques such as core-needle biopsies and surgical biopsies continue to dominate the cancer diagnostic market. A significant increase in cancer incidence is a major driver of regional market expansion.
UK Biopsy Guidance Market Analysis
The market in the UK is projected to reach a valuation of US$ 89 Million by 2032, growing at a CAGR of 6.5% from 2022 to 2032. During this period, the market is projected to garner an absolute dollar opportunity of US$ 41 Million.
Japan Biopsy Guidance Market Analysis
In Japan, the market is expected to reach US$ 78 Million by 2032. Growing at a CAGR of 7.1% from 2022 to 2032, the market in the country is expected to gross an absolute dollar opportunity of around US$ 39 Million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
During the forecast period, the stereotactically guided biopsy segment is anticipated to experience rapid expansion. New product launches, originating with new and improved product efficacy, and the introduction of technological advances using 2D-3D image guidance, will help propel the segment forward.
The combination of increased awareness and the introduction of innovative medical technologies has led to an increased demand for stereotactic-guided biopsies. In addition, the introduction of automated core biopsy guns has boosted the popularity of this method. Several medical facilities have broadened the use of stereotactic-guided biopsy to all challenging mammographic lesions.
Over the forecast period, the ultrasound-guided biopsy segment is expected to increase at the fastest rate. It is the safest and most effective imaging technique for targeting fine-needle aspirations and percutaneous biopsies. Using real-time imaging, it is a secure and controllable method for targeting needles for abdominal and pelvic tissues and masses.
It has several advantages in comparison to CT-guided biopsies, such as portability, cost, and the lack of ionizing radiation. In a safe fashion, the procedure can be carried out on a variety of lesions that are as small as 1 cm. Therefore, an ultrasound-guided biopsy is becoming increasingly popular among patients.
With many local firms vying against multinational competitors, the market is significantly fragmented. To stay competitive in the industry, major businesses are focusing more on research and development of new products.
The prominent players in the Biopsy Guidance System Market are Becton, Dickinson, and Company, Hologic, Inc., Devicor Medical Products, Inc., B. Braun Melsungen AG, and ARGON MEDICAL. Major market players use a variety of methods to preserve their dominance, including high Research and Development activity, global expansion strategies, broad product offers, and frequent introduction of advanced versions of existing items.
Some of the recent developments of key Biopsy Guidance System providers are as follows:
Similarly, the team at Future Market Insights, which is available in the full report, has tracked recent developments related to companies offering Biopsy Guidance Systems.
The global Biopsy Guidance System Market is worth more than US$ 1.1 Billion at present.
The value of the Biopsy Guidance System Market is projected to increase at a CAGR of around 5.8% from 2022 to 2032.
The value of Biopsy Guidance System Market increased at a CAGR of around 5.1% from 2017 to 2021.
The rising prevalence of cancer, the rise in the geriatric population, the growing demand for non-invasive procedures, and technological innovations are all driving the growth of the biopsy guidance system market.
The market for Biopsy Guidance System Market in China is projected to expand at a CAGR of around 7.1% from 2022 to 2032.
While the market in South Korea is expected to grow at nearly 6.7%, the market in Japan is projected to register a CAGR of nearly 7.1% from 2022 to 2032.
1. Executive Summary | Biopsy Guidance System Market 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Million) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ Million) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032 6.1. Historical Market Analysis, 2017 to 2021 6.2. Current and Future Market Projections, 2022 to 2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Value (US$ Million) Analysis, 2017 to 2021 7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Product Type, 2017 to 2021 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032 8.3.1. Stereotactic Guided Biopsy 8.3.2. Ultrasound Guided Biopsy 8.3.3. MRI Guided Biopsy 8.4. Market Attractiveness Analysis By Product Type 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2021 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032 9.3.1. Brain Biopsy 9.3.2. Breast Biopsy 9.3.3. Other Applications 9.4. Market Attractiveness Analysis By Application 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By End-User, 2017 to 2021 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End-User, 2022 to 2032 10.3.1. Hospitals 10.3.2. Specialty Clinics 10.3.3. Diagnostic Centers 10.3.4. Research and Academic Institutes 10.4. Market Attractiveness Analysis By End-User 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2021 11.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. Asia Pacific 11.3.5. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 12.4.1. By Country 12.4.1.1.United States of America 12.4.1.2. Canada 12.4.1.3. Rest of North America 12.4.2. By Product Type 12.4.3. By End-User 12.4.4. By Application 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Product Type 12.5.3. By End-User 12.5.4. By Application 13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Rest of Latin America 13.4.2. By Product Type 13.4.3. By End-User 13.4.4. By Application 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product Type 13.5.3. By End-User 13.5.4. By Application 14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. France 14.4.1.3. United Kingdom 14.4.1.4. Italy 14.4.1.5. Spain 14.4.1.6. Nordic Countries 14.4.1.7. Rest of Europe 14.4.2. By Product Type 14.4.3. By End-User 14.4.4. By Application 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product Type 14.5.3. By End-User 14.5.4. By Application 15. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 15.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 15.4.1. By Country 15.4.1.1. China 15.4.1.2. Japan 15.4.1.3. South Korea 15.4.1.4. Rest of Asia Pacific 15.4.2. By Product Type 15.4.3. By End-User 15.4.4. By Application 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product Type 15.5.3. By End-User 15.5.4. By Application 16. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 16.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 16.4.1. By Country 16.4.1.1. GCC Countries 16.4.1.2. South Africa 16.4.1.3. Turkey 16.4.1.4. Rest of Middle East and Africa 16.4.2. By Product Type 16.4.3. By End-User 16.4.4. By Application 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product Type 16.5.3. By End-User 16.5.4. By Application 17. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.1.1. Market Value Proportion Analysis, By Key Countries 17.1.2. Global Vs. Country Growth Comparison 17.2. US Market Analysis 17.2.1. Value Proportion Analysis by Market Taxonomy 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.2.2.1. By Product Type 17.2.2.2. By End-User 17.2.2.3. By Application 17.3. Canada Market Analysis 17.3.1. Value Proportion Analysis by Market Taxonomy 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.3.2.1. By Product Type 17.3.2.2. By End-User 17.3.2.3. By Application 17.4. Mexico Market Analysis 17.4.1. Value Proportion Analysis by Market Taxonomy 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.4.2.1. By Product Type 17.4.2.2. By End-User 17.4.2.3. By Application 17.5. Brazil Market Analysis 17.5.1. Value Proportion Analysis by Market Taxonomy 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.5.2.1. By Product Type 17.5.2.2. By End-User 17.5.2.3. By Application 17.6. Germany Market Analysis 17.6.1. Value Proportion Analysis by Market Taxonomy 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.6.2.1. By Product Type 17.6.2.2. By End-User 17.6.2.3. By Application 17.7. France Market Analysis 17.7.1. Value Proportion Analysis by Market Taxonomy 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.7.2.1. By Product Type 17.7.2.2. By End-User 17.7.2.3. By Application 17.8. Italy Market Analysis 17.8.1. Value Proportion Analysis by Market Taxonomy 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.8.2.1. By Product Type 17.8.2.2. By End-User 17.8.2.3. By Application 17.9. Spain Market Analysis 17.9.1. Value Proportion Analysis by Market Taxonomy 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.9.2.1. By Product Type 17.9.2.2. By End-User 17.9.2.3. By Application 17.10. UK Market Analysis 17.10.1. Value Proportion Analysis by Market Taxonomy 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.10.2.1. By Product Type 17.10.2.2. By End-User 17.10.2.3. By Application 17.11. Nordic Countries Market Analysis 17.11.1. Value Proportion Analysis by Market Taxonomy 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.11.2.1. By Product Type 17.11.2.2. By End-User 17.11.2.3. By Application 17.12. China Market Analysis 17.12.1. Value Proportion Analysis by Market Taxonomy 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.12.2.1. By Product Type 17.12.2.2. By End-User 17.12.2.3. By Application 17.13. Japan Market Analysis 17.13.1. Value Proportion Analysis by Market Taxonomy 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.13.2.1. By Product Type 17.13.2.2. By End-User 17.13.2.3. By Application 17.14. South Korea Market Analysis 17.14.1. Value Proportion Analysis by Market Taxonomy 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.14.2.1. By Product Type 17.14.2.2. By End-User 17.14.2.3. By Application 17.15. GCC Countries Market Analysis 17.15.1. Value Proportion Analysis by Market Taxonomy 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.15.2.1. By Product Type 17.15.2.2. By End-User 17.15.2.3. By Application 17.16. South Africa Market Analysis 17.16.1. Value Proportion Analysis by Market Taxonomy 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.16.2.1. By Product Type 17.16.2.2. By End-User 17.16.2.3. By Application 17.17. Turkey Market Analysis 17.17.1. Value Proportion Analysis by Market Taxonomy 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032 17.17.2.1. By Product Type 17.17.2.2. By End-User 17.17.2.3. By Application 17.17.3. Competition Landscape and Player Concentration in the Country 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 18.4. Market Presence Analysis 18.4.1. By Regional footprint of Players 18.4.2. Product footprint by Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. Becton 19.3.1.1. Overview 19.3.1.2. Product Portfolio 19.3.1.3. Sales Footprint 19.3.1.4. Strategy Overview 19.3.2. Dickinson and Company 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Sales Footprint 19.3.2.4. Strategy Overview 19.3.3. Hologic Inc 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Sales Footprint 19.3.3.4. Strategy Overview 19.3.4. Devicor Medical Products, Inc. 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Sales Footprint 19.3.4.4. Strategy Overview 19.3.5. B. Braun Melsungen AG 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Sales Footprint 19.3.5.4. Strategy Overview 19.3.6. ARGON MEDICAL 19.3.6.1. Overview 19.3.6.2. Product Portfolio 19.3.6.3. Sales Footprint 19.3.6.4. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Biopsy Guidance System Market
